Company / PP&E per Share
Stoke Therapeutics, Inc. PP&E per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.06
FY2025
5-year range
$0.06 / $0.18
FY2021-FY2025
Trend
-31.6%
vs FY2024
Sector context
#113 of 191
Health Care
What the data says
At $0.06, Stoke Therapeutics, Inc.'s pp&e per share ranks #113 of 191 in the Health Care sector. PP&E per Share has declined for 3 consecutive years, from $0.18 in FY2022 to $0.06 in FY2025.
Based on SEC 10-K filings.
0.06 in FY2025 with a 5-year CAGR of -6.1%.
Declined from $0.15 to $0.06 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -31.5%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Sector benchmark
#113 of 191 in Health CareTop 59% of 191This company $0.06 Sector average $22.34
▼
-99.7% below sector average
Key checks
Key Insights
- Stoke Therapeutics, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 31.6% year-over-year.
- Ranks #113 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -31.6% |
| FY2024 | $0.09 | -42.3% |
| FY2023 | $0.15 | -18.4% |
| FY2022 | $0.18 | +60.6% |
| FY2021 | $0.11 | +41.0% |
| FY2020 | $0.08 | -42.9% |
| FY2019 | $0.14 | -91.7% |
| FY2018 | $1.68 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026